Pegylated brain-derived neurotrophic factor shows improved distribution into the spinal cord and stimulates locomotor activity and morphological changes after injury

Experimental Neurology

Volumn 170, Issue 1, 2001, Pages 85-100

  Ankeny, Daniel P ^a   McTigue, Dana M ^a   Guan, Zhen ^a   Yan, Qiao ^b   Kinstler, Olaf ^b   Stokes, Bradford T ^a   Jakeman, Lyn B ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b AMGEN INC   (United States)

Author keywords

Air stepping; BDNF; Behavior; Central pattern generator; Contusion injury; Fos; Pegylation; Polyethylene glycol; Spinal cord injury

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; MACROGOL; NEUROTROPHIN; POLYETHYLENE GLYCOL BRAIN DERIVED NEUROTROPHIC FACTOR; PROTEIN FOS; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CHOLINERGIC NERVE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; LOCOMOTION; NERVE CELL; NERVOUS SYSTEM INJURY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD INJURY;

EID: 0034948264     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2001.7699     Document Type: Article

References (78)

1. The neurotrophins NT-4/5 and BDNF augment serotonin, dopamine, and GABAergic systems during behaviorally effective infusions to the substantia nigra
2. Differential distribution of exogenous BDNF, NGF, and NT-3 in the brain corresponds to the relative abundance and distribution of high-affinity and low-affinity neurotrophin receptors
3. Truncated and catalytic isoforms of trkB are coexpressed in neurons of rat and mouse CNS
4. A sensitive and reliable locomotor rating scale for open field testing in rats
5. Brain-derived neurotrophic factor protects against ischemic cell damage in rat hippocampus
6. Spinal cord injury produced by consistent mechanical displacement of the cord in rats: Behavioral and histologic analysis
7. Synthesis and biological activity of polyethylene glycol-mouse nerve growth factor conjugate
8. BDNF and epilepsy: Too much of a good thing?
9. NT-3, but not BDNF, prevents atrophy and death of axotomized spinal cord projection neurons
10. Neurotrophic factors increase axonal growth after spinal cord injury and transplantation in the adult rat
11. Loss of developing cholinergic basal forebrain neurons following excitotoxic lesions of the hippocampus: Rescue by neurotrophins
12. Localization and organization of the central pattern generator for hindlimb locomotion in newborn rat
13. Spinal cord repair in adult paraplegic rats: Partial restoration of hind limb function
14. Long-acting growth hormones produced by conjugation with polyethylene glycol
15. Pharmacokinetics of intrathecally applied BDNF and effects on spinal motoneurons
16. Use-dependent plasticity in spinal stepping and standing
17. Potential of adult mammalian lumbosacral spinal cord to execute and acquire improved locomotion in the absence of supraspinal input
18. Brain-derived neurotrophic factor (BDNF) modulates inhibitory, but not excitatory, transmission in the CA1 region of the hippocampus
19. Increased levels of trkB mRNA and trkB protein-like immunoreactivity in the injured rat and cat spinal cord
20. Characterization of glial trkB receptors: Differential response to injury in the central and peripheral nervous systems
21. Brain-derived neurotrophic factor induces excitotoxic sensitivity in cultured embryonic rat spinal motor neurons through activation of the phosphatidylinositol 3-kinase pathway
22. Central pattern generators for locomotion, with special reference to vertebrates
23. Facilitation by strychnine of reflex walking in spinal dogs
24. Nerve growth factor (NGF)-treated nitrocellulose enhances and directs the regeneration of adult rat dorsal root axons through intraspinal neural tissue transplants
25. Induction of c-fos-like protein in spinal cord neurons following sensory stimulation
26. L-dopa-induced air-stepping in decerebrate developing rats
27. Traumatic spinal cord injury produced by controlled contusion in mouse
28. Brain-derived neurotrophic factor stimulates hindlimb stepping and sprouting of cholinergic fibers after spinal cord injury
29. Neurotrophin-evoked rapid excitation through TrkB receptors
30. Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus
31. Distribution of central pattern generators for rhythmic motor outputs in the spinal cord of limbed vertebrates
32. Changes in truncated trkB and p75 receptor expression in the rat spinal cord following spinal cord hemisection and spinal cord hemisection plus neurotrophin treatment
33. trkA, trkB, and trkC messenger RNA expression by bulbospinal cells of the rat
34. BDNF prevents and reverses adult rat motor neuron degeneration and induces axonal outgrowth
35. The trkB tyrosine protein kinase gene codes for a second neurogenic receptor that lacks the catalytic kinase domain
36. BDNF and NT-4/5 prevent atrophy of rat rubrospinal neurons after cervical axotomy, stimulate GAP-43 and Tα1-Tubulin mRNA expression, and promote axonal regeneration
37. Potentiated necrosis of cultured cortical neurons by neurotrophins
38. BDNF and NT-4/5 enhance glutamatergic synaptic transmission in cultured hippocampal neurons
39. Brain-derived neurotrophic factor rapidly enhances synaptic transmission in hippocampal neurons via postsynaptic tyrosine kinase receptors
40. Physiology of the neurotrophins
41. Regulation of Trk receptors following contusion of the rat spinal cord
42. Nerve growth factors (NGF, BDNF) enhance axonal regeneration but are not required for survival of adult sensory neurons
43. Neurotrophic factors: From molecule to man
44. Transplants of fibroblasts genetically modified to express BDNF promote regeneration of adult rat rubrospinal axons and recovery of forelimb function
45. Potentiation of developing neuromuscular synapses by the neurotrophins NT-3 and BDNF
46. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain
47. Endogenous neuro-protection factors and traumatic brain injury: Mechanisms of action and implications for therapy
48. Expression of full-length trkB receptors by reactive astrocytes after chronic CNS injury
49. Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord
50. Schwann cells genetically modified to secrete human BDNF promote enhanced axonal regrowth across transected adult rat spinal cord
51. Acute intrahippocampal infusion of brain-derived neurotrophic factor induces lasting potentiation of synaptic transmission in the rat dentate gyrus
52. Stimulus-transcription coupling in neurons: Role of cellular immediate-early genes
53. Stimulus-transcription coupling in the nervous system: Involvement of the inducible proto-oncogenes fos and jun
54. Brain-derived neurotrophic factor (BDNF) prevents the degeneration of medial septal cholinergic neurons following fimbria transection
55. Sensorimotor stimulation to improve locomotor recovery after spinal cord injury
56. Brain-derived neurotrophic factor promotes axonal regeneration and long-term survival of adult rat spinal motoneurons in vivo
57. Alteration in extracellular amino acids after traumatic spinal cord injury
58. Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery
59. Combined use of carboxyl-directed protein pegylation and vector-mediated blood-brain barrier drug delivery system optimizes brain uptake of brain-derived neurotrophic factor following intravenous administration
60. Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury
61. Biological interventions for spinal cord injury
62. Receptor binding activities of biotinylated derivatives of β-nerve growth factor
63. Early response genes as markers of neuronal activity and growth factor action
64. Carboxyl-directed pegylation of brain-derived neurotrophic factor markedly reduces systemic clearance with minimal loss of biologic activity
65. Degeneration and regeneration of axons in the lesioned spinal cord
66. Suppression and transient induction of lymphokines in cancer patients after administration of polyethylene glycolated interleukin-2
67. BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administration
68. An electromechanical spinal injury device with dynamic sensitivity
69. Synaptic modulation by neurotrophic factors: Differential and synergistic effects of brain-derived neurotrophic factor and ciliary neurotrophic factor
70. Response of rubrospinal and corticospinal neurons to injury and neurotrophins
71. Neurotrophins and neuronal plasticity
72. Chemical modification of natural human tumor necrosis factor-alpha with polyethylene glycol increases its anti-tumor potency
73. L-dopa-induced air-stepping in developing rats
74. Neuroprotection with non-invasive neurotrophin delivery to the brain
75. Distribution of intracerebral ventricularly administered neurotrophins in rat brain and its correlation with trk receptor expression
76. Treatment of the chronically injured spinal cord with neurotrophic factors can promote axonal regeneration from supraspinal neurons